New medicines are desperately needed to treat a growing number of drug-resistant infections, but many companies developing the drugs are short on cash and investments.
Published: July 9, 2020 at 09:29PM
from NYT Health https://ift.tt/3gJ96gp
New medicines are desperately needed to treat a growing number of drug-resistant infections, but many companies developing the drugs are short on cash and investments.
Published: July 9, 2020 at 09:29PM
from NYT Health https://ift.tt/3gJ96gp